ACP Journal Club. Review: DOACs do not differ from standard anticoagulants for recurrent VTE; factor Xa inhibitors reduce bleeding.

Ryan D. Watkins,M. Rondina
DOI: https://doi.org/10.7326/ACPJC-2015-163-8-003
IF: 39.2
2015-10-20
Annals of Internal Medicine
Abstract:Source Citation Robertson L, Kesteven P, McCaslin JE.Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane Database Syst Rev. 2015;6:CD010...
What problem does this paper attempt to address?